Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B.

Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B. Abstract Text:

    he-jun yuanHe-Jun Yuan,danny ka-ho wongDanny Ka-Ho Wong,joke doutreloigneJoke Doutreloigne,erwin sablonErwin Sablon,ching-lung laiChing-Lung Lai,man-fung yuenMan-Fung Yuen,

    OBJECTIVE: To determine the prevalence of precore and core promoter (CP) mutations before, at and after HBeAg seroclearance in Chinese patients. METHODS: Precore and CP mutations were determined in 93 patients with chronic hepatitis B 12-24 months before, at and 12 months after the time of HBeAg seroclearance. RESULTS: No significant changes were found in the prevalence of precore or CP mutations before, at and after HBeAg seroclearance. Seven patients (7.8%) had HBeAg seroreversion within 1 year of HBeAg seroclearance. There was no significant difference in the prevalence of precore and CP mutations between patients with and without HBeAg seroreversion. 68.3% and 48.7% of patients harbored the same precore and CP genotypes throughout. 32.0% patients with precore mutations and 8.9% patients with CP mutations before HBeAg seroclearance had reversion to wild type within 1 year of HBeAg seroclearance. Patients with genotype C patients had a higher prevalence of CP mutations before HBeAg seroclearance compared with patients with genotype B (82.4% vs. 44%, P=0.001). CONCLUSIONS: Precore and CP mutations existed in a substantial proportion of Chinese patients before HBeAg seroclearance. The replication of precore and, to a lesser extent, CP mutants could be suppressed around the time of HBeAg seroclearance.

    Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B. Publishing Authors By Initials

    hj yuanHJ Yuan,d ka-ho wongD Ka-Ho Wong,j doutreloigneJ Doutreloigne,e sablonE Sablon,cl laiCL Lai,mf yuenMF Yuen,

    For similar proteins: protein precursors research abstracts see: proteins: protein precursors research

    PUBMED ID PMID:

    MEDLINE DATE:

    Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Journal of infection

    VOLUME: 54

    Page Numbers: 497-503

    Journal Abbreviation: J. Infect.

    ISSN: 1532-2742

    DAY: 25

    MONTH: 09

    YEAR: 2006

    Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7908424

    Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B. Keywords Mesh Terms:

    KEYWORDS: Protein Precursors

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B. Information

    Substance Name: Protein Precursors

    Registry Number: 0

    Grant and Affiliation Information for Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B.

    AFFILIATION: Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong, PR China.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Infect

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News